Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation

O Koniev, A Wagner - Chemical Society Reviews, 2015 - pubs.rsc.org
Bioconjugation methodologies have proven to play a central enabling role in the recent
development of biotherapeutics and chemical biology approaches. Recent endeavours in …

Protein neddylation: beyond cullin–RING ligases

RI Enchev, BA Schulman, M Peter - Nature reviews Molecular cell …, 2015 - nature.com
NEDD8 (neural precursor cell expressed developmentally downregulated protein 8) is a
ubiquitin-like protein that activates the largest ubiquitin E3 ligase family, the cullin–RING …

Molecular basis for ubiquitin/Fubi cross-reactivity in USP16 and USP36

R O'Dea, N Kazi, A Hoffmann-Benito, Z Zhao… - Nature Chemical …, 2023 - nature.com
Ubiquitin and ubiquitin-like proteins typically use distinct machineries to facilitate diverse
functions. The immunosuppressive ubiquitin-like protein Fubi is synthesized as an N …

A genomic and functional inventory of deubiquitinating enzymes

SMB Nijman, MPA Luna-Vargas, A Velds… - Cell, 2005 - cell.com
Posttranslational modification of proteins by the small molecule ubiquitin is a key regulatory
event, and the enzymes catalyzing these modifications have been the focus of many studies …

Screening of DUB activity and specificity by MALDI-TOF mass spectrometry

MS Ritorto, R Ewan, AB Perez-Oliva, A Knebel… - Nature …, 2014 - nature.com
Deubiquitylases (DUBs) are key regulators of the ubiquitin system which cleave ubiquitin
moieties from proteins and polyubiquitin chains. Several DUBs have been implicated in …

Chemical modification of proteins at cysteine: opportunities in chemistry and biology

JM Chalker, GJL Bernardes, YA Lin… - Chemistry–An Asian …, 2009 - Wiley Online Library
Cys‐tematic modification: Cysteine is a versatile amino acid for selective chemical
modification of proteins. Both chemical and biological innovations made possible by …

Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events

S Arastu-Kapur, JL Anderl, M Kraus, F Parlati… - Clinical Cancer …, 2011 - AACR
Abstract Purpose: Bortezomib (Velcade), a dipeptide boronate 20S proteasome inhibitor and
an approved treatment option for multiple myeloma, is associated with a treatment …

Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ

JE Brownell, MD Sintchak, JM Gavin, H Liao… - Molecular cell, 2010 - cell.com
The NEDD8-activating enzyme (NAE) initiates a protein homeostatic pathway essential for
cancer cell growth and survival. MLN4924 is a selective inhibitor of NAE currently in clinical …

Identification of highly selective covalent inhibitors by phage display

S Chen, S Lovell, S Lee, M Fellner, PD Mace… - Nature …, 2021 - nature.com
Molecules that covalently bind macromolecular targets have found widespread applications
as activity-based probes and as irreversibly binding drugs. However, the general reactivity of …

Mechanism-based profiling of enzyme families

MJ Evans, BF Cravatt - Chemical reviews, 2006 - ACS Publications
Genome sequencing projects have ushered biological research into a new age where
scientists are confronted with the daunting undertaking of assigning functions to the full …